Neko Health Raises $260M, Eleos Health Secures $60M, and AI Optics Gets FDA Clearance

Hi there,

In this edition of Life AI Weekly, we're diving into the latest developments in AI chips and data centers. Springbok Analytics has successfully raised $5 million to advance its muscle health technology, showcasing the growing interest and investment in AI-driven healthcare solutions. Meanwhile, AI Optics has received FDA clearance for its Sentinel Camera, a significant step forward in AI-powered medical imaging technology.

Additionally, Perthera is set to present its AI Chemo Predictor at the 2025 Symposium, highlighting the potential of AI in personalizing cancer treatment. In the realm of business and investments, Eleos Health has secured $60 million to enhance AI applications in behavioral healthcare, reflecting the increasing integration of AI in diverse healthcare sectors. Stay tuned as we explore these exciting advancements and their implications for the future of AI in healthcare and beyond.

Median Technologies has obtained up to €47.5 million to aid in regulatory filings and the commercialization of its AI lung cancer diagnostic tool, eyonis™, with plans for U.S. and EU market entry. Eleos Health Inc. has secured $60 million in Series C funding to enhance its AI-powered behavioral healthcare platform. Neko Health, co-founded by Spotify's Daniel Ek, has raised $260 million in Series B funding, valuing the company at $1.8 billion.

Tevogen Bio Holdings Inc. and Microsoft discussed AI's impact on drug development at the J.P. Morgan Healthcare Conference, highlighting the role of clean data and responsible AI practices. Lindus Health, a London-based startup, has raised $55 million in Series B funding to enhance clinical trials with AI, aiming to streamline drug development processes. AllSci has launched a Development Partner Program to assist life science organizations in enhancing their research and development efforts in pharmaceuticals and biotechnology using its AI platform.

NeurEYE is using AI and eye scans from Scottish optometrists to assess dementia risk and brain health under the NEURii initiative. Researchers at Cedars-Sinai and the University of Pennsylvania have developed MISO, an AI tool for analyzing biological data to identify disease structures. Arzeda has secured funding from DARPA to advance its AI platform for designing novel proteins, aiding national security and health applications.

Springbok Analytics has completed a $5 million Series A funding round to advance its AI-driven muscle health analysis technology, with backing from Transition Equity Partners, LLC, the NBA, and others. AI Optics Inc. has received FDA clearance for its Sentinel Camera, a handheld device aimed at improving access to retinal disease screening by addressing specialist shortages and costs. Perthera will present its AI-driven chemotherapy predictor, PDACai, at the 2025 ASCO Gastrointestinal Cancers Symposium, aiming to enhance treatment decisions for pancreatic cancer patients. Corti has launched specialized AI models for healthcare to enhance efficiency and accuracy, addressing challenges with general-purpose AI models in medical settings. Datar Cancer Genetics has launched an AI-driven video-reporting service to assess chemotherapy effectiveness on tumor cells, aiming to personalize cancer treatment and reduce ineffective therapies.